Fineotex Chemical Limited (FCL) AI Stock Analysis

6 Followers

Fineotex Chemical Limited

(NSE:FCL)

Select Model

Rating:69Neutral

Price Target:INR 57.00▲(10.36% Upside)

Action:downgraded

Date:10/07/26

The score is driven primarily by strong profitability and a conservatively positioned balance sheet, supported by positive technical trend and momentum. The main constraints are weak recent cash flow (negative operating/free cash flow in FY2026) and a high valuation (P/E 49.33 with low yield), which meaningfully temper the overall rating.

Positive Factors

Strong Revenue GrowthThe sharp FY2026 revenue rebound, following substantial earlier growth, indicates expanding business scale and renewed demand for Fineotex’s specialty chemical offerings. Sustained top-line expansion can strengthen customer reach, improve operating leverage, and support reinvestment over the next several quarters.

Negative Factors

Weak Recent Cash ConversionThe shift from strong operating cash generation in FY2023–FY2025 to negative operating cash flow in FY2026 creates a meaningful gap between reported profits and cash realization. Continued cash absorption could reduce funding flexibility and increase reliance on balance-sheet resources.

Fineotex Chemical Limited (FCL) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 61.46B
Dividend Yield: 0.25%
Average Volume (3M): 1.42M
Price to Earnings (P/E): 42.9
Beta (1Y): 1.11
Revenue Growth: 91.44%
EPS Growth: 19.67%
Country: India
Employees: 214
Sector: General
Sector Strength: 55
Industry: Chemicals - Specialty

Fineotex Chemical Limited Business Overview & Revenue Model

Company Description

Founded in 1979 and based in Mumbai, India, Fineotex Chemical Limited is a global manufacturer and distributor of a broad spectrum of specialty and auxiliary chemicals. The company develops tailored chemical solutions for the textile industry, coveri...

Fineotex Chemical Limited Financial Statement Overview

Summary

Strong income statement and balance sheet (Income Statement Score 84; Balance Sheet Score 91) support solid profitability and low leverage, but the weak cash conversion is a material offset (Cash Flow Score 52) with negative operating and free cash flow in FY2026 despite strong profit growth.

Income Statement

84Very Positive

Balance Sheet

91Very Positive

Cash Flow

52Neutral

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	10.12B	7.72B	5.33B	5.69B	5.17B	3.67B
Gross Profit	2.76B	2.01B	2.06B	2.17B	1.78B	1.30B
EBITDA	1.96B	1.68B	1.52B	1.65B	1.13B	767.24M
Net Income	1.22B	1.09B	1.08B	1.20B	883.16M	551.74M
Balance Sheet
Total Assets	0	11.59B	8.15B	5.48B	4.22B	3.39B
Cash, Cash Equivalents and Short-Term Investments	732.33M	732.33M	330.01M	735.06M	611.90M	308.35M
Total Debt	0	81.96M	2.17M	51.90M	72.80M	19.08M
Total Liabilities	-9.40B	2.19B	757.59M	945.90M	659.02M	700.96M
Stockholders Equity	9.40B	8.82B	7.31B	4.47B	3.49B	2.62B
Cash Flow
Free Cash Flow	81.22M	-476.20M	-73.46M	494.76M	887.62M	-91.37M
Operating Cash Flow	200.95M	-222.29M	693.34M	973.81M	1.08B	133.75M
Investing Cash Flow	-51.66M	987.46M	-2.73B	-468.50M	-1.03B	-7.44M
Financing Cash Flow	-49.37M	-611.54M	1.76B	-239.11M	-64.39M	-56.59M

Fineotex Chemical Limited Technical Analysis

Technical Analysis SentimentNeutral

Last Price51.65

Price Trends

50DMA54.21Negative

100DMA47.68Positive

200DMA37.12Positive

Market Momentum

MACD-0.75Negative

RSI47.82Neutral

STOCH61.77Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FCL, the sentiment is Neutral. The current price of 51.65 is below the 20-day moving average (MA) of 52.38, below the 50-day MA of 54.21, and above the 200-day MA of 37.12, indicating a neutral trend. The MACD of -0.75 indicates Negative momentum. The RSI at 47.82 is Neutral, neither overbought nor oversold. The STOCH value of 61.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:FCL.

Fineotex Chemical Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:FCL against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:FCL	69Neutral	INR 61.47B	42.92	―	0.25%	91.44%	19.67%
IN:ROSSARI	65Neutral	INR 23.55B	15.58	―	0.12%	19.76%	11.74%
IN:SUDARSCHEM	62Neutral	INR 83.86B	126.95	―	0.82%	48.73%	59.17%
IN:BALAMINES	58Neutral	INR 58.20B	24.85	―	0.61%	20.91%	62.44%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:BODALCHEM	47Neutral	INR 20.21B	29.41	―	―	27.57%	135.05%
IN:CAMLINFINE	42Neutral	INR 15.10B	304.77	―	―	8.40%	―

* General Sector Average

Performance Comparison

IN:FCL and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:FCL	Fineotex Chemical Limited	51.65	26.67	106.73%
IN:BALAMINES	Balaji Amines Limited	1822.45	568.41	45.33%
IN:BODALCHEM	Bodal Chemicals Limited	160.95	102.53	175.50%
IN:CAMLINFINE	Camlin Fine Sciences Limited	79.27	-91.68	-53.63%
IN:ROSSARI	Rossari Biotech Ltd	429.45	-198.24	-31.58%
IN:SUDARSCHEM	Sudarshan Chemical Industries Limited	1165.25	101.95	9.59%

Fineotex Chemical Limited Corporate Events

Fineotex Forms U.S. Step-Down Subsidiary to Drive Specialty Chemicals Expansion

Sep 1, 2026

Fineotex Chemical Limited has expanded its global structure by incorporating a wholly owned step-down subsidiary, Fineotex Holdings Inc., in the U.S. state of Delaware through its existing subsidiary Fineotex Biotex HealthGuard FZE. The new entity, w...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 07, 2026

Fineotex Chemical Limited AI Stock Analysis